Adhesion to substrates induces dendritic cell endothelization and decreases immunological response

Immunobiology

Volumn 218, Issue 1, 2013, Pages 64-75

  Osterbur, Jacob ^a   Sprague, Leslee ^b   Muccioli, Maria ^c   Pate, Michelle ^a   Mansfield, Kristen ^a   McGinty, John ^a   Li, Yihan ^c,d   Li, Yandi ^c,d   Shirure, Venktesh ^b   Courreges, Maria Cecilia ^a   Benencia, Fabian ^a,b,c  

^a OHIO UNIVERSITY   (United States)

^b US Institute of Navigation   (United States)

^c OHIO UNIVERSITY   (United States)

^d CAPITAL NORMAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Antigen presentation; Dendritic cells; Endothelial markers; Ovarian cancer

Indexed keywords

ANGIOPOIETIN RECEPTOR; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OX40 LIGAND; RNA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIZATION; FEMALE; GENE EXPRESSION; HISTOGENESIS; IMMUNE RESPONSE; INFLAMMATION; MALIGNANT ASCITES; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD; CADHERINS; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE, TUMOR; DENDRITIC CELLS; ENDOTHELIUM; FEMALE; HUMANS; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OVARIAN NEOPLASMS; RECEPTOR, TIE-2; TUMOR MICROENVIRONMENT; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84870289369     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.02.003     Document Type: Article

References (77)

1. Adams S., Facciabene A., McCann G., Jean S., Peng X., Gamerman V., Gimotty P., Coukos G. Intraperitoneal Injection of Ascites-derived Antigen-presenting Cells Following Ex Vivo Treatment with Toll-like Receptor Agonists Confers Significant Protection Against Tumor Challenge 2010, S156 pp.
2. Allavena P., Sica A., Solinas G., Porta C., Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 2008, 66:1.
3. Baleeiro R.B., Anselmo L.B., Soares F.A., Pinto C.A., Ramos O., Gross J.L., Haddad F., Younes R.N., Tomiyoshi M.Y., Bergami-Santos P.C., Barbuto J.A. High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-alpha in lung cancer. Cancer Immunol. Immunother. 2008, 57:1335.
4. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767.
5. Benencia F., Courreges M.C., Conejo-Garcia J.R., Mohamed-Hadley A., Zhang L., Buckanovich R.J., Carroll R., Fraser N., Coukos G. HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer. Mol. Ther. 2005, 12:789.
6. Benencia F., Courreges M.C., Conejo-Garcia J.R., Buckanovich R.J., Zhang L., Carroll R.H., Morgan M.A., Coukos G. Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma. Hum. Gene Ther. 2005, 16:765.
7. Benencia F., Courreges M.C., Fraser N.W., Coukos G. Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation. Cancer Biol. Ther. 2008, 7:1194.
8. Bianco N.R., Kim S.H., Morelli A.E., Robbins P.D. Modulation of the immune response using dendritic cell-derived exosomes. Methods Mol. Biol. 2007, 380:443.
9. Bobryshev Y.V., Lord R.S. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc. Res. 1998, 37:799.
10. Bobryshev Y.V., Tran D., Killingsworth M.C., Buckland M., Lord R.V. Dendritic cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus. J. Gastrointest. Surg. 2009, 13:442.
11. Bonasio R., von Andrian U.H. Generation, migration and function of circulating dendritic cells. Curr. Opin. Immunol. 2006, 18:503.
12. Buckanovich R.J., Facciabene A., Kim S., Benencia F., Sasaroli D., Balint K., Katsaros D., O'Brien-Jenkins A., Gimotty P.A., Coukos G. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat. Med. 2008, 14:28.
13. Conejo-Garcia J.R., Benencia F., Courreges M.C., Kang E., Mohamed-Hadley A., Buckanovich R.J., Holtz D.O., Jenkins A., Na H., Zhang L., Wagner D.S., Katsaros D., Caroll R., Coukos G. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 2004, 10:950.
14. Conejo-Garcia J.R., Buckanovich R.J., Benencia F., Courreges M.C., Rubin S.C., Carroll R.G., Coukos G. Vascular leukocytes contribute to tumor vascularization. Blood 2005, 105:679.
15. Coukos G., Benencia F., Buckanovich R.J., Conejo-Garcia J.R. The role of dendritic cell precursors in tumour vasculogenesis. Br. J. Cancer 2005, 92:1182.
16. Cubillos-Ruiz J.R., Engle X., Scarlett U.K., Martinez D., Barber A., Elgueta R., Wang L., Nesbeth Y., Durant Y., Gewirtz A.T., Sentman C.L., Kedl R., Conejo-Garcia J.R. Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. J. Clin. Invest. 2009, 119:2231.
17. Cubillos-Ruiz J.R., Fiering S., Conejo-Garcia J.R. Nanomolecular targeting of dendritic cells for ovarian cancer therapy. Future Oncol. 2009, 5:1189.
18. Curiel T.J., Cheng P., Mottram P., Alvarez X., Moons L., Evdemon-Hogan M., Wei S., Zou L., Kryczek I., Hoyle G., Lackner A., Carmeliet P., Zou W. Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res. 2004, 64:5535.
19. Diebold S.S., Montoya M., Unger H., Alexopoulou L., Roy P., Haswell L.E., Al-Shamkhani A., Flavell R., Borrow P., Reis e Sousa C. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003, 424:324.
20. Djonov V., Baum O., Burri P.H. Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res. 2003, 314:107.
21. Dominguez P.M., Ardavin C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol. Rev. 2010, 234:90.
22. Donohue P.J., Richards C.M., Brown S.A., Hanscom H.N., Buschman J., Thangada S., Hla T., Williams M.S., Winkles J.A. TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler. Thromb. Vasc. Biol. 2003, 23:594.
23. Engel D., Dobrindt U., Tittel A., Peters P., Maurer J., Gutgemann I., Kaissling B., Kuziel W., Jung S., Kurts C. Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance. Infect. Immun. 2006, 74:6100.
24. Fainaru O., Adini A., Benny O., Adini I., Short S., Bazinet L., Nakai K., Pravda E., Hornstein M.D., D'Amato R.J., Folkman J. Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis. FASEB J. 2008, 22:522.
25. Fernandez Pujol B., Lucibello F.C., Gehling U.M., Lindemann K., Weidner N., Zuzarte M.L., Adamkiewicz J., Elsasser H.P., Muller R., Havemann K. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 2000, 65:287.
26. Fernandez Pujol B., Lucibello F.C., Zuzarte M., Lutjens P., Muller R., Havemann K. Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. Eur. J. Cell Biol. 2001, 80:99.
27. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 2004, 25:581.
28. Ferrara N. VEGF as a therapeutic target in cancer. Oncology 2005, 69(Suppl. 3):11.
29. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669.
30. Gabrilovich D.I., Chen H.L., Girgis K.R., Cunningham H.T., Meny G.M., Nadaf S., Kavanaugh D., Carbone D.P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 1996, 2:1096.
31. Gabrilovich D.I., Ishida T., Nadaf S., Ohm J.E., Carbone D.P. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin. Cancer Res. 1999, 5:2963.
32. Gilboa E., Vieweg J. Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol. Rev. 2004, 199:251.
33. Gingis-Velitski S., Zetser A., Flugelman M.Y., Vlodavsky I., Ilan N. Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J. Biol. Chem. 2004, 279:23536.
34. Glod J., Kobiler D., Noel M., Koneru R., Lehrer S., Medina D., Maric D., Fine H.A. Monocytes form a vascular barrier and participate in vessel repair after brain injury. Blood 2006, 107:940.
35. Gotsman I., Sharpe A.H., Lichtman A.H. T-cell costimulation and coinhibition in atherosclerosis. Circ. Res. 2008, 103:1220.
36. Gottfried E., Kreutz M., Haffner S., Holler E., Iacobelli M., Andreesen R., Eissner G. Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis. Scand. J. Immunol. 2007, 65:329.
37. Grolleau-Julius A., Abernathy L., Harning E., Yung R.L. Mechanisms of murine dendritic cell antitumor dysfunction in aging. Cancer Immunol. Immunother. 2009, 58:1935.
38. Heath W.R., Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 2001, 19:47.
39. Huarte E., Tirapu I., Arina A., Vera M., Alfaro C., Murillo O., Palencia B., Busto V., Marin V., Mazzolini G., Melero I. Intratumoural administration of dendritic cells: hostile environment and help by gene therapy. Expert Opin. Biol. Ther. 2005, 5:7.
40. Huarte E., Cubillos-Ruiz J.R., Nesbeth Y.C., Scarlett U.K., Martinez D.G., Buckanovich R.J., Benencia F., Stan R.V., Keler T., Sarobe P., Sentman C.L., Conejo-Garcia J.R. Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. Cancer Res. 2008, 68:7684.
41. Kenny P.A., Lee G.Y., Bissell M.J. Targeting the tumor microenvironment. Front. Biosci. 2007, 12:3468.
42. Kogata N., Arai Y., Pearson J.T., Hashimoto K., Hidaka K., Koyama T., Somekawa S., Nakaoka Y., Ogawa M., Adams R.H., Okada M., Mochizuki N. Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization. Circ. Res. 2006, 98:897.
43. Lanzavecchia A., Sallusto F. The Instructive Role of Dendritic Cells on T Cell Responses: Lineages, Plasticity and Kinetics 2001, 291 pp.
44. Lewis C.E., De Palma M., Naldini L. Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res. 2007, 67:8429.
45. Liu Y.J., Kanzler H., Soumelis V., Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2001, 2:585.
46. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 2002, 23:445.
47. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999, 223:77.
48. Lutz M.B., Schnare M., Menges M., Rossner S., Rollinghoff M., Schuler G., Gessner A. Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF. J. Immunol. 2002, 169:3574.
49. Macary P.A., Too C.T., Dai X. Targeting tumours by adoptive transfer of immune cells. Clin. Exp. Pharmacol. Physiol. 2006, 33:569.
50. Mantovani A., Sozzani S., Locati M., Schioppa T., Saccani A., Allavena P., Sica A. Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Novartis Found. Symp. 2004, 256:137.
51. Muccioli M., Pate M., Omosebi O., Benencia F. Generation and labeling of murine bone marrow-derived dendritic cells with qdot nanocrystals for tracking studies. J. Vis. Exp. 2011, (52), pii: 2785.
52. Murdoch C., Muthana M., Coffelt S.B., Lewis C.E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 2008, 8:618.
53. Nakai K., Fainaru O., Bazinet L., Pakneshan P., Benny O., Pravda E., Folkman J., D'Amato R.J. Dendritic cells augment choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2008, 49:3666.
54. Nakano H., Lin K.L., Yanagita M., Charbonneau C., Cook D.N., Kakiuchi T., Gunn M.D. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat. Immunol. 2009, 10:394.
55. Nakayama M., Harada N., Okumura K., Yagita H. Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies. Biochem. Biophys. Res. Commun. 2003, 306:819.
56. Osada T., Chong G., Tansik R., Hong T., Spector N., Kumar R., Hurwitz H.I., Dev I., Nixon A.B., Lyerly H.K., Clay T., Morse M.A. The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients. Cancer Immunol. Immunother. 2008, 57:1115.
57. Papetti M., Herman I.M. Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol. 2002, 282:C947.
58. Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J. Neurooncol. 2000, 50:1.
59. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 2003, 4:33.
60. Roby K.F., Taylor C.C., Sweetwood J.P., Cheng Y., Pace J.L., Tawfik O., Persons D.L., Smith P.G., Terranova P.F. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 2000, 21:585.
61. Scheeren R.A., Koopman G., Van der Baan S., Meijer C.J., Pals S.T. Adhesion receptors involved in clustering of blood dendritic cells and T lymphocytes. Eur. J. Immunol. 1991, 21:1101.
62. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59.
63. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7:19.
64. Shurin M.R., Shurin G.V., Lokshin A., Yurkovetsky Z.R., Gutkin D.W., Chatta G., Zhong H., Han B., Ferris R.L. Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?. Cancer Metastasis Rev. 2006, 25:333.
65. Simon J.C., Hara H., Denfeld R.W., Martin S. UVB-irradiated dendritic cells induce nonproliferating, regulatory type T cells. Skin Pharmacol. Appl. Skin Physiol. 2002, 15:330.
66. Sozzani S., Rusnati M., Riboldi E., Mitola S., Presta M. Dendritic cell-endothelial cell cross-talk in angiogenesis. Trends Immunol. 2007, 28:385.
67. Sprague L., Muccioli M., Pate M., Meles E., McGinty J., Nandigam H., Venkatesh A.K., Gu M.Y., Mansfield K., Rutowski A., Omosebi O., Courreges M.C., Benencia F. The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells. BMC Immunol. 2011, 12:35.
68. Tian F., Grimaldo S., Fujita M., Cutts J., Vujanovic N.L., Li L.Y. The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation. J. Immunol. 2007, 179:3742.
69. Vicari A.P., Chiodoni C., Vaure C., Ait-Yahia S., Dercamp C., Matsos F., Reynard O., Taverne C., Merle P., Colombo M.P., O'Garra A., Trinchieri G., Caux C. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J. Exp. Med. 2002, 196:541.
70. Whiteside T.L. The role of immune cells in the tumor microenvironment. Cancer Treat. Res. 2006, 130:103.
71. Xu Y., Zhan Y., Lew A.M., Naik S.H., Kershaw M.H. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J. Immunol. 2007, 179:7577.
72. Yamagami S., Usui T., Amano S., Ebihara N. Bone marrow-derived cells in mouse and human cornea. Cornea 2005, 24:S71.
73. Yilmaz A., Lochno M., Traeg F., Cicha I., Reiss C., Stumpf C., Raaz D., Anger T., Amann K., Probst T., Ludwig J., Daniel W.G., Garlichs C.D. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004, 176:101.
74. Yrlid U., Svensson M., Johansson C., Wick M.J. Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response. FEMS Immunol. Med. Microbiol. 2000, 27:313.
75. Yu Q., Toole B.P. Common pattern of CD44 isoforms is expressed in morphogenetically active epithelia. Dev. Dyn. 1997, 208:1.
76. Zhang L., Yang N., Garcia J.R., Mohamed A., Benencia F., Rubin S.C., Allman D., Coukos G. Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. Am. J. Pathol. 2002, 161:2295.
77. Zhang L., Conejo-Garcia J.R., Yang N., Huang W., Mohamed-Hadley A., Yao W., Benencia F., Coukos G. Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells. Biochem. Biophys. Res. Commun. 2002, 292:860.